Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Curious about which cash back credit cards don't charge an annual fee? Discover options that allow you to earn rewards without extra costs.
26,317 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Long-running dividend growers are showing resilience as 2026 markets churn. AWR and NFG lead a small group with 50+ y...
This week, newmont stock dropped over 10% as traders weighed shifting gold prices and fresh company data. The move hi...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Despite the everyday label of 'dull,' transportation stocks move goods and markets. In 2026, two names shine with str...
As AI momentum intensifies, investors re-evaluate three tech leaders. This report examines MSFT, DELL, and INTEL to a...
As AI drives demand for faster memory and smarter processors, Micron and Intel stand out for different reasons. This ...
Planet Labs stock popped today after a standout quarter and optimism about a path to profitability. This article brea...
Alphabet’s Q1 2026 results show a rapid profit pace that dwarfs Meta’s earnings, underscoring a widening gap in AI-dr...
BBB Foods reports Q1 2026 results with modest revenue growth and steadier margins. This review translates the transcr...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...